A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Golcadomide plus R-CHOP chemotherapy vs placebo plus R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (GOLSEEK-1)
Sprache der Kurzfassung:
Deutsch
Englische Bezeichnung:
A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Golcadomide plus R-CHOP chemotherapy vs placebo plus R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (GOLSEEK-1)
Forschungs-